TAZOCIN 2.25 G.

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

PIPERACILLIN AS SODIUM 2 G/VIAL; TAZOBACTAM SODIUM 0.25 G/VIAL

Mevcut itibaren:

NEOPHARM LTD

ATC kodu:

J01CR05

Farmasötik formu:

POWDER FOR SOLUTION FOR INJECTION

Uygulama yolu:

I.V

Tarafından üretildi:

WYETH PIPER. DIV.OF WYETH HOLDINGS CORP.

Terapötik grubu:

PIPERACILLIN AND ENZYME INHIBITOR

Terapötik endikasyonlar:

Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Yetkilendirme tarihi:

2010-06-01